Peter Rickli

Corporate Officer/Principal at The Genetics Co., Inc.

Health Technology

Health Services

Network origin in Peter Rickli first degree

Entity	Entity type	Industry
The Genetics Co., Inc. The Genetics Co., Inc. Medical/Nursing ServicesHealth Services The Genetics Company is a privately held drug discovery and development company active in the areas of cancer and neurodegenerative diseases. The company has identified small molecule inhibitors of two proprietary targets with in the Wnt-pathway, which is believed to play a crucial role in colon cancer. It has also identified small molecule inhibitors of BACE (beta-amyloid converting enzyme). In parallel, the company has identified and is in the process of further characterizing a series of novel growth-related drug target candidate genes for exploitation in cancer therapy. Headquartered in Zurich-Schlieren, Switzerland, the company currently has 29 employees. The Genetics Company offers you a range of high quality products to analyze Amyloid beta peptides x-40 and x-42 for basic research but also for pre-clinical and clinical development and in vitro diagnostics (IVD). Its CE-certified ELISA kits are the only clinically validated products for the determination of the Abeta42/40-Ratio in human CSF. These kits enable the early diagnosis of incipient Alzheimer's disease and can be used for patient stratification and monitoring in clinical trials of Alzheimer drug candidates. 3	Private Company	Medical/Nursing Services	3

Chart of Companies connected to the second degree

Multi-company connection

Companies connected to Peter Rickli via their personal network

Company	Sector	Related people	Main position
AC IMMUNE SA	Pharmaceuticals: Major	Hans-Beat Gürtler	Director/Board Member
TRACON PHARMACEUTICALS, INC.	Pharmaceuticals: Major	Alfred Scheidegger	Director/Board Member
Stanford University	College/University	Rudolf Gygax	Undergraduate Degree
Elanco Tiergesundheit AG Elanco Tiergesundheit AG Pharmaceuticals: MajorHealth Technology Elanco Tiergesundheit AG manufactures animal vaccines. The firm provides pet health, livestock and Bioprotection products. The company's products include Atopica, Capstar, Deramaxx, Fortekor, Interceptor, Milbemax, Parc-tic and Sentinel. It is headquartered in Basel, Switzerland.	Pharmaceuticals: Major	Hans-Beat Gürtler	Chief Executive Officer
Nextech Invest AG Nextech Invest AG Investment ManagersFinance Nextech Invest AG (Nextech) is an independent venture capital firm with headquarters in Zurich, Switzerland. It was founded by Alfred Scheidegger in 1998. Nextech's investors include public pension funds, banks, asset management companies and Swiss and German high-net worth individuals.	Investment Managers	Rudolf Gygax Alfred Scheidegger	Private Equity Investor Chief Executive Officer
BASILEA PHARMACEUTICA AG	Pharmaceuticals: Major	Hans-Beat Gürtler	Director/Board Member
Varuma AG		Hans-Beat Gürtler	Corporate Officer/Principal
SANTHERA PHARMACEUTICALS HOLDING AG	Pharmaceuticals: Major	Rudolf Gygax	Corporate Officer/Principal
DOTTIKON ES HOLDING AG	Chemicals: Specialty	Alfred Scheidegger	Director/Board Member
Novartis Venture Funds Novartis Venture Funds Investment ManagersFinance Novartis Venture Funds (NVF) is a venture capital firm with headquarters in Basel, Switzerland and an additional office in Cambridge, MA. The firm was founded in 1996. NVF is a subsidiary of Novartis AG (VX: NOVN) and was created following the 1996 merger of Ciba-Geigy and Sandoz.	Investment Managers	Rudolf Gygax	President
University of Basel	College/University	Rudolf Gygax Alfred Scheidegger	Undergraduate Degree Doctorate Degree
Swiss Federal Institute of Technology	College/University	Alfred Scheidegger	Chief Administrative Officer
IMPLENIA AG	Engineering & Construction	Hans-Beat Gürtler	Director/Board Member
Kyoto University	College/University	Alfred Scheidegger	Graduate Degree
NOVIMMUNE SA	Medical/Nursing Services	Hans-Beat Gürtler	Director/Board Member
Covagen AG Covagen AG BiotechnologyHealth Technology Covagen AG engages in the research in as well as development, production, and distribution of pharmaceutical and diagnostic products and technologies. The company was founded by Julian Bertschinger and Dragan Grabulovski in 2007 and is headquartered in Zug, Switzerland.	Biotechnology	Rudolf Gygax	Chairman
SynphaBase AG SynphaBase AG Miscellaneous Commercial ServicesCommercial Services SynphaBase AG provides contract research and development services to the pharmaceutical and chemical industry. Its products and services include route finding and process development, production of multi-kg up to metric tons, lab scale synthesis and carbohydrates and glycans. The firm’s catalogue includes monosaccharides as building blocks for glycan synthesis with various protecting group patterns and linker systems, disaccharides, oligosaccharides, glycosyl amino acids; core structures and building blocks for carbohydrate-based vaccine. The company was founded by in Arthur Bodenmüller in December 2000 and is headquartered in Pratteln, Switzerland.	Miscellaneous Commercial Services	Rudolf Gygax	Director/Board Member
Dottikon Exclusive Synthesis AG Dottikon Exclusive Synthesis AG Pharmaceuticals: MajorHealth Technology Dottikon Exclusive Synthesis AG manufactures pharmaceutical ingredients. Its products and services exclusive synthesis, project management, performance chemicals, containment, quality management, recycling and waste treatment, and dottisol. The company was founded in 1913 and is headquartered in Dottikon, Switzerland.	Pharmaceuticals: Major	Alfred Scheidegger	Director/Board Member
Nextech III GP AG		Alfred Scheidegger	Director/Board Member
Basel Chamber of Commerce Basel Chamber of Commerce Miscellaneous Commercial ServicesCommercial Services The Basel Chamber of Commerce is an organization that advocates for the interests of the industry and promotes the region as the most important logistics hub in Switzerland. The non-profit company is based in Basel, Switzerland. The company also has a Swiss School for International Business.	Miscellaneous Commercial Services	Hans-Beat Gürtler	Corporate Officer/Principal
Mahissa		Hans-Beat Gürtler	Chief Executive Officer
Cleave Therapeutics, Inc. Cleave Therapeutics, Inc. BiotechnologyHealth Technology Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA.	Biotechnology	Alfred Scheidegger	Director/Board Member
Nextech Holding AG		Alfred Scheidegger	Chairman
Dottikon Es Management AG		Alfred Scheidegger	Director/Board Member
Swiss Scientific Computing Center Swiss Scientific Computing Center Miscellaneous Commercial ServicesCommercial Services The Swiss Scientific Computing Center develops and provides supercomputing capabilities to solve important problems in science and society. The private company is based in Manno, Switzerland.	Miscellaneous Commercial Services	Alfred Scheidegger	Chief Executive Officer
Nextech Venture Principals Ltd. Nextech Venture Principals Ltd. Financial ConglomeratesFinance Nextech Venture Principals Ltd. provides investment services. The private company is based in Jersey.	Financial Conglomerates	Alfred Scheidegger	Director/Board Member
Rising Tide Foundation	Investment Trusts/Mutual Funds	Alfred Scheidegger	Director/Board Member
8stogg AG		Alfred Scheidegger	Director/Board Member
Wemedoo AG		Alfred Scheidegger	Chairman
Kenta Biotech AG Kenta Biotech AG BiotechnologyHealth Technology Kenta Biotech AG engages in the research, development, production, and marketing of biotechnological and pharmaceutical products. It also specializes in the discovery and development of monoclonal antibodies for the treatment of life-threatening hospital infections. The company was founded by Alois B. Lang on February 9, 2006 and is headquartered in Zug, Switzerland.	Biotechnology	Hans-Beat Gürtler	Director/Board Member